Company
Therapeutic Areas
Our Pipeline
News
Careers
Contact Us
Select Year
2026
2025
2024
2023
2022
2026.09.03
NeuShen Therapeutics Completes $80M Series B Financing to Expand Global Clinical Development of Innovative CNS Pipeline
2026.07.08
NeuShen Therapeutics Celebrates New Headquarters in Shanghai Zhangjiang Twin Towers
2026.02.02
NeuShen Therapeutics Announces Completion of Series A+ Round Financing
2026.01.02
NeuShen Therapeutics Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NS-136 in Agitation in Alzheimer’s Disease (AAD)
About Us
Mission & Culture
Leadership Team
Depression
Schizophrenia
Neurological Disorders
Pipeline
Clinical Trials
Publications
Copyright © 2025 NeuShen Therapeutics, Inc. All rights reserved.